PSI's Pharmaceutical Statistics Journal Club is a free-to-attend virtual meeting which takes place quarterly. PSI members and non-members alike are welcome to join the meetings. Journal Club meetings feature papers from PSI's official journal Pharmaceutical Statistics which is published by John Wiley & Sons, Ltd. The authors of two papers are invited to present their work and each presentation is followed by a discussion.
The full version of the papers being presented at each meeting are freely available to all for a period around the Journal Club meeting date. The details of upcoming meetings will always be available on this page.
Journal Club meetings are recorded and made available via psiweb.org. Individual presentations and the audio recordings can be accessed from psiweb.org shortly after the event.
Click here for details of all previous meetings.
How does PSI's Pharmaceutical Statistics Journal Club work?
For further information or to provide feedback on PSI's Pharmaceutical Statistics Journal Club, please contact journalclub@psiweb.org.
Further details on
Wiley, sponsor of PSI's PST Journal Clubs can be found at www.wiley.com. For details of other PSI Events please visit the events page, or for information on joining PSI please click here.
Our monthly webinar explores examples of innovative data visualisations relevant to our day to day work. Each month a new dataset is provided from a clinical trial or other relevant example, and participants are invited to submit a graphic that communicates interesting and relevant characteristics of the data.
This presentation will give some background regarding the ‘Carcinogenicity Statistics Discussion Group’. The talk will review the history of the group, outline the current status, and give an overview of the types of topics discussed.
This year's Annual General Meeting will focus on how PSI has navigated the challenges of the past year and adapted to the new online world, as well as how we plan to embrace a new Board structure and new opportunities as we move forward.
Our next journal club features two papers on the topic of “The Use of External Controls in Clinical Trials”. Please join us to hear Chris Harbron (Roche) and Margaret Gamalo (Pfizer) present their recent work. The webinar will be chaired by Nigel Stallard (Warwick University).
We’re now searching at all levels for Biostatisticians and Statistical Programmers to join our International BARDS Health Technology Assessment team at our London and Zurich hubs.
The Associate Director of Biostatistics is the key client interface for all statistical issues and discussions.
In this role you will consult in the design of complex and innovative studies and clinical trial programs as well as Leading DMC/DSMB processes.
This is an excellent opportunity for someone that loves working directly with clients, contributing as a high-level project lead and key contributor.
As a seasoned Biostatistician, will work primarily on Immunology: GI and Dermatology trials with a focus on Late Phase studies. Some PK Analysis experience highly desired.
As a seasoned Biostatistician, will work primarily in late phase oncology.
As an experienced pharmaceutical statistician, you will support Cytel and a client of our Functional Service Provider (FSP) division.
As a Sr Bios, you will function independently as Lead Statistician on projects and support/project statistician on others.
As a Sr Mgr, Biostatistics you will manage a team of Statisticians and Programmers within the FSP department, as well as managing project work.
As a Senior or Principal Biotatistician, you will hold a combined project leadership and hands-on technical statistics role, working across a range of phases and therapeutic areas.
You will participate in the development of study protocols including participation in study design discussions and sample size calculations, and review CRFs and data review guidelines.
As a Senior or Principal Statistician, you will hold a combined project leadership and hands-on technical statistics role., working across a range of phases and therapeutic areas.
We are looking for passionate and motivated statisticians to work within our Services team to deliver high quality, innovative, analytical services within a clinical setting as our KerusCloud platform moves into the next phase.
Would you like to join a dynamic, growing firm where you can really make an impact, not just on the company but to accelerate drug development and ultimately benefit patients?
Have you experience in the application of statistics in the pharmaceutical, healthcare or life science sectors? Do you want to be at the forefront of statistical innovations, leading the way on clinical trial design and analysis?
As a Statistics Manager, you will hold a combined line management, project leadership and technical statistical role, working across a range of phases and therapeutic areas.
